A Study to Evaluate Rucaparib in Combination With Other Anticancer Agents in Participants With a Solid Tumor (SEASTAR)
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Ovarian Cancer|Triple-negative Breast Cancer|Urothelial Carcinoma|Solid Tumor
Interventions: DRUG: Rucaparib|DRUG: Lucitanib|DRUG: Sacituzumab govitecan
Sponsor: pharmaand GmbH
Collaborators: Gilead Sciences